CG Oncology (CGON) Total Current Liabilities (2023 - 2026)
CG Oncology's (CGON) quarterly Total Current Liabilities came in at $35.2 million in Q1 2026, up 55.53% YoY from $22.6 million in Q1 2025, and up 14.2% on a QoQ basis from $30.8 million in Q4 2025.
CG Oncology (CGON) Total Current Liabilities (2023 - 2026) Analysis & Trends
CG Oncology (CGON) has 4 years of Total Current Liabilities data on file, last reported at $35.2 million in Q1 2026.
- Quarterly Total Current Liabilities rose 55.53% year-over-year to $35.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.2 million (up 55.53% YoY) and the FY2025 annual result came in at $30.8 million, up 44.31% from the prior year.
- Total Current Liabilities grew to $35.2 million in Q1 2026, from $30.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $35.2 million in Q1 2026 to a low of $10.0 million in Q1 2024.
- A 4-year average of $22.3 million and a median of $22.0 million in 2024 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 156.31% in 2025, down 44.31% in 2025.
- Tracing CGON's Total Current Liabilities over 4 years: stood at $14.3 million in 2023, then soared by 49.91% to $21.4 million in 2024, then surged by 44.31% to $30.8 million in 2025, then grew by 14.2% to $35.2 million in 2026.
- The last three Total Current Liabilities figures came in at $35.2 million (Q1 2026), $30.8 million (Q4 2025), and $30.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | 47.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.24 Mn |
| Mar 31, 2026 | 35.22 Mn |
| Dec 31, 2025 | 30.84 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Jun 30, 2025 | 30.38 Mn |
| Mar 31, 2025 | 22.64 Mn |
| Dec 31, 2024 | 21.37 Mn |
| Sep 30, 2024 | 15.63 Mn |
| Jun 30, 2024 | 11.85 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Dec 31, 2023 | 14.25 Mn |